preview ep stapl group report
preview ep week twelv compani report
highlight key point group perspect head ep
lower beverag estim revis beverag estim
post ep report last tuesday cautiou
beverag demand weak post group downgrad
first half march april updat wors even lower
consensu forecast drive neg revis ccep
report may put result context
consensu revenu came larg post
nearli sinc februari
beverag see outlier shift at-hom coffe consumpt
see separ alphawis survey publish yesterday
off-set away-from-hom beverag weak post covid
expect soft vs consensu hurt time prospect improv
post expect favor april commentari call pepsi-cola see
opposit scenario strong organ sale caution like
top-line prospect remain ow rate high convict
lt thesi tie pepsi-cola snack strength robust categori growth
pepsi-cola strong competit posit corpor result aid mix shift
higher growth higher margin snack busi short-term
bit back forth top-line expect first lower
organ sale beverag demand risk subsequ rais strong
snack scanner data lower y-o-i organ sale
growth prior post weak april beverag demand outlook
lower ep growth y-o-i ex fx prior
believ stock could take short-term paus result given high bar
stock outperform ytd vs ko pepsi-cola
popular beverag name mid-april investor survey net posit
respons well like revenu guide-down pepsi-cola intern
result non-uk market two month intern
beverag result particularli weak march/april peak covid
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
impact away home demand weak addit difficult
organ sale comparison howev still remain confid
ow lt thesi one key point believ investor
fulli focus structur pepsi-cola lt market share acceler
post covid use dsd distribut scale lead higher veloc
brand gain shelf space share snack covid environ
premium smaller competitor like impair long-term
short-term covid weak beverag also see pepsi-cola advantag vs
competit much lower away-from-hom market share limit
near-term demand destruct covid enabl pepsi-cola keep
invest drive long-term share rel beverag competit coupl
higher invest alreadi occur y-o-i ad spend
increas new ceo increasingli bullish pepsi-cola market share
emerg market pressur see outlook emerg market
continu deterior covid case ramp short-term also less
abil geographi shape recoveri less fiscal stimulu
potenti less robust health care system fx pressur add risk
typic price lever off-set fx difficult compani less
will take price fragil consum environ and/or govern
mandat price control recommend two-em centric name
cl ow despit context given view busi categori
rel defens cl case could benefit trade-down
portfolio gener price competit cl index vs global
toothpast categori exampl gener view mondelez
defens indulg natur portfolio creat demand
risk weaker macro emerg market revis fy organ
sale growth assumpt intern sale
revis off-set partial higher na forecast potenti cautiou
forward commentari high bar favor food
compani sentiment mid april investor survey weight averag
could caus pressur short-term around ep howev long-term
see magnitud risk manag build momentum clearli
evid pre-covid market share volum result post strategi chang
last coupl year trust excel manag team manag
well build share come em pressur similar
evid recent scanner data result china
term individu name highlight thought key focu point
compani head ep page focu point ep
name frame refer crowd name tactic
pleas see chart mid-april investor survey highlight
exhibit pg beverages/hpc name view favor
investor survey
exhibit view posit food/tobacco
estim price chang updat estim price
target follow compani summar tabl
refin model head ep season also revis estim
name last week
exhibit summari estim chang
ccep
exhibit summari price target chang
focu point ep name
keurig dr pepper expect focu vs time dynam expect
miss favor april/boy commentari importantli magnitud
demand shift at-hom coffe consumpt post covid structur shift
could long-term well weak away-from-hom beverag
heritag dp side recent alphawis survey net number consum
increas coffe pod consumpt compar one month ago
pepsi-cola net impact organ sale like big focu investor split
degre snack upsid off-set beverag weak well
commentari em although pepsi-cola na skew two-third profit vs mega-cap peer
limit rel em risk comment pepsi-cola recent rockstar acquisit potenti
distribut agreement bang also focu see like revenu beat
revenu guid
coca-cola european partner provid trade updat includ
top-line result result last tuesday indic global volum
y-o-i april alreadi lower bar believ focu ccep
level declin april forward commentari recoveri
european countri start process reopen economi
expect focu molson coor ep expect weak
on-premis channel estim sale us canada uk
partial off-set acceler off-premis channel also believ investor
focu center potenti long-term favor market share
implic volum consum trade-down beer higher us
unemploy weaker macro recent beer distributor survey
distributor indic expect trade-down beer categori post-covid
final expect investor remain focus debt leverag liquid
updat whether manag reorgan plan chang post covid
mondelez focu like em commentari challeng
piec portfolio post covid environ gum candi sale mix
india/brazil combin hsd sale mix extent off-set
clear na/europ strength post covid track channel pickup commentari
china also import appear rebound well post
covid weak also note like greater cost headwind
peer geograph spread suppli chain footprint
view stock posit trade around quarter like
optimist messag new ceo outlook post covid full detail
wait strateg review investor like focu sustain
demand benefit covid post alreadi pre-releas posit result
expect focu net covid top-line benefit portfolio less
posit impact na post covid lower degre center store food focu
 us track channel sale last four week vs
less favor greater intern exposur sale mix vs
well chang plan reinvest
initi disappoint guidanc fiscal year
church dwight expect investor focu organ sale growth
outlook much recent scanner data strength consum stock-up vs
increas underli demand well commentari growth trend post covid
area less visibl lower mix track channel scanner data waterpik
flawless trojan condom batist dri shampoo anim nutrit well eventu
potenti benefits/risk trade fairli mix portfolio premium
valu also expect benefit lower commod cost
focu
colgat expect focu forward commentari emerg market organ
sale growth risk extent fx pressur defens colgat product categori
proven far sustain pickup soap categori demand
potenti risk less profession recommend post covid environ
dentist oral care vet pet care dermatologist skin care
lauder market like brace weak fiscal commentari
like matter fiscal result market like look ahead
commentari durat extent potenti travel retail recoveri fiscal
risk perman store closur us/europ china trend lead
indic given covid situat improv recent rebound although
note mainland china clearli see signific channel shift travel
would expect focu extent macro risk
discretionari part newel portfolio potenti benefit product
cocoon home cooking-rel product etc well newel liquid situat
updat sec subpoena receiv januari regard
compani sale certain account practic
believ main focu extent manag expect
higher cleaning/wip demand longer term extent suppli
constraint well potenti regain distribut point rest portfolio
point also expect impact lower commod cost
exhibit pg beverages/hpc name view favor investor
exhibit view posit food/tobacco
schedul report date monday april close ms estim
focu point expect focu ep expect
growth inflect telegraph would soft expect
benefit consum pantri load coffe beverag post covid
skew neg impact on-premis beverag weak
start impact result ko result lower legaci dp
organ sale growth off-set higher coffe growth consum
shift coffe consumpt at-hom brewer pantri load expect
investor focu also potenti long-term benefit coffe
brewer household penetr increas coffe pod consumpt
consum cocoon home less away-from-hom coffe consumpt
also expect investor focus liquid cash flow given high
debt leverag increas focu revers factor program
although see limit risk front
organ sale growth model y-o-i organ sale growth
comparison expect neg impact weak on-
premis beverag busi hospitality/offic coffe busi
benefit higher consum demand pantri load beverages/coffe pod
skew telegraph late march investor call given
time lag distribut system reli independ
distributor partner particularli coffe shipment go coffe
partner hit retail shelv
acceler yoy well
averag basi us scanner data sale
similarli acceler
scanner data sale growth carbon soft drink
csd acceler yoy driven
volum given pantry-load less price/mix vs
volume-driven growth csd contrast
histor price/mix driven trend price/mix
off-set declin volum
volum growth us single-serv coffe categori track channel
rebound deceler rang prior two
quarter vs histor rang note untrack channel trend
also like strong said mention expect benefit
higher pod consumpt materi result
averag basi volum growth similarli re-acceler
line histor rang
prior four quarter retail price front appli see
us singl serv coffe price/mix yoy slightli
histor trend
howev flag low visibl kgm price driven lack price
detail contract coffe partner long-term contract partner
scanner data price trend partner retail reflect
exhibit singl serv coffe pod categori acceler
exhibit us scanner sale acceler strong
guidanc cpg compani withdrew guidanc
re-affirmed guidanc march subsequ march
investor call expect reiter guidanc ep includ
top-line growth y-o-i ep growth y-o-i
estim price target updat ko result tuesday lower
legaci dp growth assumpt reflect declin on-premis
sale off-set increas coffe system volum reflect higher
home coffe brewer/pod consumpt pantri load ep
estim unchang also rais price target
base price-to-earnings ev/ebitda reflect higher
note financi result us canada report basi end
intern oper month januari februari
reflect result except uk
focu point expect strong organ sale growth
greater snack demand see risk guid revenu first
expect away from-home-beverag soft neg commentari
indic global volum april particularli true
given pepsi-cola intern busi outsid uk report two
month result mean march away home demand weak
fulli captur note pepsi-cola eating/din sale much smaller
sale sale vs ko on-premis weak
partial off-set acceler off-premis well snack
busi sale roughli two-third profit defens
benefit consum cocoon home second
difficult organ sale growth comparison thu lower
top-line prior organ top-line
prior expect robust result organ sale
growth continu snack strength away-from-hom beverag declin
ow thesi stock could take paus quarterli result high
bar pepsi-cola popular name among beverag mid-april investor
survey net posit respons like revenu guide-down still
view pepsi-cola clear ow one key point think investor
fulli focus structur believ pepsi-cola lt market share
rise post covid use dsd distribut advantag scale lead higher
veloc brand gain shelf space share snack covid environ
premium smaller competitor like impair long-term
short-term covid weak beverag also see pepsi-cola advantag vs
competit much lower away-from-hom share enabl pepsi-cola
keep invest drive long-term share rel beverag competit coupl
higher invest alreadi occur ad spend
increas new ceo increasingli bullish pepsi-cola market share
rockstar acquisit updat expect provid updat recent
announc rockstar acquisit expect close shortli recent
ftc approv plan within energi drink categori includ
potenti distribut deal bang view deal pricey particularli given
weak rockstar perform pay obtain meaning
exposur energi categori believ three key growth area
deal revit rockstar brand us well
intern brand under-penetr free
opportun expand mountain dew brand within energi drink space
opportun expand partnership within energi drink space
believ could result distribut smaller energi drink brand
bang celsiu cellucor detail pleas see note initi thought
pepsi-cola acquir rockstar convers manag
organ sale growth forecast y-o-i organ sale growth
prior reflect stronger snack trend post covid includ
scanner data strength base volum growth price/mix
averag basi model organ sale growth
aid higher demand us pantri load snack
segment basi expect solid growth flna qfna
strong us demand pantri load evid us scanner data pbna
aid off-premis pickup off-set partial weaker away home
trend intern busi januari februari
report uk three month expect solid growth
latin america given mainli snack busi segment sale
covid-rel weak start march report
amesa europ model organ sale growth
hand expect declin apac china weak assum china
us scanner data updat scanner data off-premis us
sale result strong us end shift
away -from-hom demand at-hom particularli snack consum
pantri load fear shown total compani us track
channel scanner data sale growth acceler y-o-i vs
segment basi largest acceler
quaker food north america qfna grew y-o-i us scanner
data covid-rel pantri load vs prior four quarter
frito-lay north america flna also post strong result y-o-i us
scanner data vs prior four quarter pepsi-cola beverag
north america pbna also acceler y-o-i us scanner data
vs prior four quarter
exhibit driven strong flna scanner data
exhibit lesser extent pbna off-premis
european scanner data european scanner data sale growth y-
o-i acceler versu
aid relat pantri load
averag basi european scanner sale vs
fx impact due signific strengthen us dollar
believ provid updat fx impact topline/ep
forecast y-o-i top-line /ep headwind vs prior guidanc
top-line ep base spot rate use multipli
top-line ep fx impact line prior guidanc averag
multipli prior five year
exhibit estim top-line ep impact
estim price target updat ep estim tick penni
higher organ sale growth discuss howev ep
fall reflect lower top-line estim ep
impli msd ex-fx ep growth prior guidanc
note ccep provid trade updat april includ top-line
result ccep releas full result top-line result
consist mani european peer
focu point ccep provid trade updat april includ
top-line result ko result last tuesday indic global
volum y-o-i april alreadi lower bar
believ focu ccep level declin territori april
also importantli forward commentari recoveri
european countri start process reopen economi
believ investor also focus liquid cash flow ccep
suspend share repurchas program late march announc board
review dividend
organ sale growth forecast organ sale declin y-o-i
prior reflect better result ko ccep one-
less sell day worth bp neg impact weak
on-premis channel sale assum march
ko result commentari april volum lower
ccep organ sale growth vs prior estim reflect
declin on-premis channel lsd growth off-premis
ko comment europ growth ep ko provid follow
commentari europ report ko emea segment emea unit case
volum even strong growth februari off-set coronavirus-
relat impact march term market strong growth across nigeria
east north africa off-set declin western europ south africa
european off-premis scanner data acceler on-premis weak
ccep off-premis scanner data sale base proxi includ coca-cola
monster sale spain germani franc uk yoy
two-year averag aid higher consum
demand pantry-load y-o-i two-year averag
y-o-i two-year averag howev mention
expect on-premis trend weak particularli march
scanner data countri countri basi ccep off-premis scanner data
sale unit kingdom yoy two-year averag
slightli y-o-i prior four quarter two-
year averag ccep off-premis sale spain yoy two-
year averag well y-o-i prior four
quarter two-year averag ccep off-premis sale franc
yoy two-year averag y-o-i
prior four quarter two-year averag ccep off-premis sale
germani yoy two-year averag
y-o-i prior four quarter two-year averag
guidanc ccep withdrew guidanc march suspend
share repurchas program time given signific volatil covid-
impact ccep busi believ ccep provid full updat
guidanc give commentari april trend similarli ko
estim updat ep estim fall prior
reflect lower top-line estim post ko result
y-o-i vs prior estim net modestli higher top-line
schedul report date tuesday april close ms estim
focu point mondelez focu like em commentari
challeng piec portfolio post covid environ gum candi
sale mix india/brazil combin hsd sale mix extent
off-set clear na/europ strength post covid track channel
pickup commentari china appear rebound well
post covid weak note em categori exposur
gener defens nonetheless weight indulg categori
less defens food stapl meanwhil also note like
greater cost headwind peer widespread geograph mix
see risk around softer forward commentari high bar
favor sentiment mid-april investor survey
weight averag revis fy organ sale growth
near intern revis partial off-set higher na forecast
long-term see overal magnitud risk manag addit
build momentum clearli evid pre-covid build market share
volum result strateg chang last year trust excel
manag team manag well build share come em pressur
similar evid recent scanner data result china
strong forward outlook expect solid quarter acceler
top-line growth organ sale yoy vs prior
quarter back pantry-load consumpt boost month march
us scanner sale grew yoy quarter march vs
expect investor focu mostli top-line
outlook balanc year expect fy guidanc
pull expect commentari potenti softer emerg market
trend covid macro pressur
us scanner data updat us scanner data growth yoy
robust growth month march weekli trend indic
pantry-load consumpt like peak mid-march last end
show sequenti deceler yoy growth
compar yoy us scanner sale growth growth
western european scanner data updat european scanner sale
yoy end yoy prior
growth larg volum driven yoy roughli line growth
broader european packag food space yoy
fx impact updat intern market north america repres
sale mix forecast fx bp headwind
top-line regard intern market expect manag discuss
pantry-load tailwind europ mix build macro challeng
latin america mix challeng sequenti improv
estim pt updat rais organ sale forecast bp
reflect strong us/european scanner data said lower
balanc year organ sale growth forecast reflect expect macro
challeng emerg market latam/amea net consider
ep estim lower
focu point expect focu ep expect
weak on-premis channel estim sale us
canada uk partial off-set acceler off-premis channel
consum pantri load also believ investor focu
potenti long-term market share implic volum consum
trade-down beer higher us unemploy weaker macro final
expect investor remain focus debt leverag liquid
organ sale growth forecast y-o-i organ sale declin vs
prior model us impli scanner data
histor gap reflect on-premis weak discuss model
europ organ sale growth y-o-i vs prior canada
y-o-i vs prior reflect on-premis weak
us scanner data updat off-premis scanner data us
sale result strong us consum pantri load
fear shift beer consumpt away-from-hom at-hom
away-from-hom trend clearli weaker on-premis bar/restaur
traffic weak shown total compani us track channel scanner
data sale growth acceler y-o-i vs
histor us track channel scanner data
good indic report us deplet growth averag gap
report result vs scanner data bp last twelv quarter
howev given larg expect declin us on-premis channel
us sale expect expect larg neg bp
gap us str estim us scanner volum growth
assum declin on-premis busi
growth off-premis
exhibit forecast larger due on-premis
guidanc thought march withdrew beyond
guidanc due uncertainti relat neg impact on-
premis busi given continu volatil impact busi
uncertainti recoveri believ provid full
updat guidanc expect provid non-explicit forward
color top-line largest expect neg impact
refer prior withdrawn guidanc includ
constant currenc sale flat -lsd y-o-i ebitda -hsd y-
o-i /-
estim updat ep estim fall
reflect lower top-line forecast higher assum de-lever
oper profit line
point view stock posit trade around quarter
like optimist messag new ceo outlook post covid full
detail wait strateg review investor like focu
sustain demand benefit covid post alreadi pre-releas
posit top-line pre-releas pre-releas posit top-line guidanc
april press releas see note detail indic expect
organ sale growth quarter roughli bp ahead pre-covid
estim although full impact top-line acceler driven higher
demand pantry-load volum partli us partli intern
region well although lesser extent entir flow
bottom line volum ramp-up requir increment
production/manufactur cost near-term like continu posit
trade quarter high short-term visibl greater consum demand
allevi debt leverag concern off-set long-term concern
around categori exposur compani posit
strateg review along guidanc manag announc would
push back strateg review earli may light covid
us scanner trend like us packag food name saw signific
acceler us scanner sale growth month march scanner sale
yoy end vs prior
vs recent period scanner sale
yoy latest week end line deceler seen
across packag food space late
unchang estimates/pt updat estim pt april
follow manag guidanc releas see note
maintain forecast time
exhibit weekli us scanner sale slow
exhibit us scanner sale extrem strong
focu point church dwight expect investor focu
organ sale growth outlook much recent scanner data strength
simpli consum stock-up vs increas underli demand well commentari
growth trend post covid area less visibl lower mix track
anim nutrit well eventu potenti benefits/risk trade
fairli mix portfolio premium valu also expect benefit
lower commod cost focu
organ sale growth forecast yoy organ sale growth
averag acceler vs yoy
averag given increas consum demand tailwind covid-rel
pantry-load us track channel scanner sale growth acceler
yoy basi vs prior year period averag scanner
trend also increas stabl growth past sever
us scanner trend like household product compani us scanner
sale trend acceler yoy reach
back covid-rel pantry-
load note growth came well averag
large-cap household product compani clx/pg/cl/kmb given larger
exposur laundri categori benefit much pantry-
load chd growth exclud flawless flawless yoy
slightli better declin although expect continu
challeng consum cocoon home social distanc
order stronger sale vs
overal chd growth balanc price/mix
volum rel histor price/mix driven sale prior four quarter
averag compris price/mix volum march market
share improv bp compar bp market share loss
flat trend march share loss remain pronounc contracept
categori bp liquid laundri share turn neg bp vs bp
averag gain prior four quarter partial off-set share gain vitamin
us laundri categori deceler liquid laundri categori
track channel sale mix scanner sale rose yoy categori
vs sale liquid laundri rose yoy
bp yoy market share loss quarter promot activ liquid
laundri categori fallen substanti particularli march driven pg
exhibit weekli us scanner sale deceler last
level
thought quarter
ep estim consensu
forecast organ sale growth vs comparison
consider pick us scanner data sale growth well strength
untrack channel e-commerc club expect yoy
specialti product growth easi comparison
anticip oper margin contract bp yoy bp higher
consensu sequenti improv bp yoy contract
reflect moder market expens bp sale y-o-i bp
y-o-i expans sg sale gm expans forecast gm
bp yoy price benign commod environ
point case across packag food space expect solid
top-line perform covid-rel demand pantri load
tailwind support strong sequenti acceler organ sale growth
vs prior quarter expect key focu remain post-
covid driver top-line growth net see solid fy organ sale
growth increas at-hom consumpt packag food partial
off-set foodservic mix conveni channel mix
weak long-term note product categori defens
geographic-weight categori growth shown resili past
recess minim deceler vs also expect
hear call chang previous plan reinvest
fx updat compar high fx exposur within us packag
food space us sale mix gis/khc/hsi averag
forecast bp fx translat headwind top-line
mostli sale exposur latin america
us scanner data updat given greater demand consum pantry-load
mid-march us scanner sale yoy consider
higher scanner
sale mainli driven volum contrast histor price/mix driven
growth yoy similar volum
declin yoy categori
scanner sale trend cereal improv inflect posit yoy vs
prior declin although highlight lost market share us scanner
data month march bp yoy vs bp time
period growth snack categori similarli acceler salti
snack sale vs nielsen western
european scanner sale also acceler sale vs
highlight last strong
driven cereal sale
rais estim maintain pt remain ew rais balanc year
organ sale growth outlook reflect sustain demand growth
at-hom consumpt packag food slightli rais
ep pt remain unchang valu
price-to-earnings
last week
thought quarter
ep estim consensu
forecast organ sale growth yoy well
given temporari tailwind covid-rel pantry-load
higher at-hom consumpt packag food
forecast oper margin bp yoy slight improv
bp yoy declin gross margin trend improv bp yoy vs
bp bp given forecast top-line acceler like
less promot activ quarter off-set ineffici overal model
oper profit ex-fx yoy vs
colgat expect focu forward commentari emerg market organ sale
growth risk extent fx pressur defens colgat product categori
far potenti risk less profession recommend post
covid environ dentist oral care vet pet care dermatologist skin care
expect solid cl estim corpor organ sale growth
slightli consensu driven north america growth aid greater us
consum demand pantri load partial off-set softer result china
expect investor focus cl boy organ revenu growth outlook
worri emerg market trend although note cl defens portfolio
limit trade-down risk cl portfolio price discount competitor global
organ sale growth forecast cl organ sale growth y-o-i
driven covid-rel demand/pantri load north america mse
y-o-i europ mse well continu momentum pet mse
also model solid organ sale growth latin america mse
africa/eurasia mse impact region toward
end march model softer result asia pacif mse due
us scanner data updat cl us scanner data sale growth strong
y-o-i covid-rel consum pantri load acceler vs
histor averag gap
report scanner data bp shown howev
conserv model bp gap north america sale
growth reflect lower shipment growth retail sale growth given retail sale
strength end quarter said believ could upsid
estim given strength untrack e-commerc channel
exhibit conserv assum larger usual gap
european scanner data updat cl european scanner data sale strong
aid covid-rel pantri load well
emerg market potenti weak one key debat cl around
potenti em weak softer macro govern mandat stay-at-
home order sever countri includ key cl market brazil india
mexico understand concern agre broader cpg concern
covid sever like linger given em countri like less abl
off-set macro pressur fiscal respons ill could linger
less abl hospit system worker lower dispos incom
like continu work price increas less like stress consum
environ govern control fx pressur rise dollar
clearli key risk factor colgat sale exposur
emerg market expect colgat manag well environ
given cl categori defens natur shown consist geographic-
weight colgat categori growth prior downturn
limit trade risk given colgat portfolio price categori
global basi us ii privat label penetr lower cl
categori vs hpc categori reduc risk trade-down
fx updat anoth key debat cl anticip fx impact given
signific strengthen us dollar believ ko provid
updat fx impact topline/report ep forecast
y-o-i top-line headwind vs cl prior impli guidanc flat
y-o-i ep headwind key driver
consensu ep estim cl
guidanc due volatil impact busi particularli
emerg market fx headwind believ cl withdraw
guidanc similarli major cpg peer said believ cl could still
achiev organ sale growth line prior guidanc
consist april investor sentiment survey investor
expect rang weight averag respons
estim price target updat ep estim tick
estim tick reflect higher fx
headwind balanc year
thought quarter
ep estim in-lin recent updat consensu cent
report consensu
forecast cl organ sale growth y-o-i volume/mix
price y-o-i comparison organ sale growth forecast driven
covid-rel pantri load us/europ model growth north
america growth europ well continu momentum pet
also model solid organ sale growth latin america africa/eurasia
impact region toward end march
model softer result asia pacif mse due china-rel weak
forecast oper margin bp y-o-i model bp
gross margin expans price benefit bp fund growth
bp off-set fx/commod headwind bp gross margin expans
partial off-set bp y-o-i increas spend sale albeit
smaller increas previous anticip due
focu point investor focu like extent
compani expect see higher cleaning/wip demand sustain long-term
abil meet consum demand increas suppli well
expect shelf space gain balanc portfolio previous
announc plan also expect benefit lower commod cost
focu
expect strong quarter focu sustain top-line momentum
expect post strong fiscal given spike consum demand
disinfect household cleaner product covid environ lead
higher consumpt month march us scanner sale trend
strongest coverag sale week end reach record
level acceler vs forecast
higher organ sale growth balanc calendar year versu pre-
covid estim higher consumpt household clean
product throughout although forecast organ sale growth
peak forecast organ sale growth vs balanc calendar
strong scanner data trend household product compani
coverag signific acceler us scanner sale post
covid-rel pantry-load sale yoy reach
averag well histor flattish -lsd declin trend growth
mainli driven categori clean segment clean wipe
household cleaner also gain market share bp month
march consider improv averag bp loss prior
exhibit weekli us scanner sale began deceler
exhibit us scanner sale consider acceler
fx updat larg exposur us keep fairli insul
currenc headwind forecast bp fx translat impact
top-line latin america pressur
updat estim rais ep respect
higher balanc year organ sale growth forecast weekli
scanner sale trend remain strong reinforc view demand
household clean product sustain calendar
point el market like brace weak fiscal commentari
market like look ahead commentari durat extent
potenti travel retail recoveri fiscal risk perman store closur
us/europ china trend lead indic rebound
although mainland china clearli see channel shift travel retail
organ sale growth forecast el organ sale growth driven
weak travel retail estim y-o-i china forecast
fiscal assum organ sale declin travel retail yoy
america china shift mix chines travel
use purchas travel retail forecast buoy oreal commentari
regard strength e-commerc china region recoveri
lower estim lower ep estim
light worsen travel retail estim travel retail forecast
fiscal
thought quarter
expect ep consensu part due
above-consensu top-line gross margin estim
forecast local currenc sale declin comparison
segment forecast america post local currenc declin vs
comparison emea vs comparison asia pacif
forecast oper margin contract bp y-o-i vs bp
comparison driven bp y-o-i gross margin contract exacerb
bp increas sg expens sale given signific sale de-lever
investor focu post-covid outlook expect neg covid
impact top-line growth given discretionari natur much
compani portfolio except cooking-rel product may see
lift consum cocoon home forecast top-line declin
believ untrack channel e-commerc see lift
off-set closur largest brick mortar custom
organ sale growth trend forecast local currenc sale declin
comparison segment forecast applianc cookwar
post local currenc declin vs flat comparison outdoor
live vs comparison learn develop vs
comparison food commerci vs comparison
us scanner data updat sale growth us scanner data
consum
increasingli cull retail shop face heighten macroeconom concern
particular categori pressur result covid-
write y-o-i march scanner data food beverag contain
babi accessori home school suppli although
note demand recaptur e-commerc
lower price target lower price target given
increas fundament risk macro pressur
exhibit us scanner sale continu declin
exhibit sale growth trend deceler recent
superior top-line trend given favor exposur attract categori
pt deriv price-to-earnings slightli lt histori reect near-
top beverag pick
top beverag pick forecast
pepsi-cola post superior top-line growth
rel peer driven exposur
categori prot snack
higher growth categori given shift
pressur health/wel vs
beverag lead share
share gain higher margins/ro
forecast bp margin expans
strong price power cost cut
pepsi slight ev/ebitda discount
qualiti superior balanc sheet
marketing/innov drive bp
volum top-line upsid limit covid-
impact price bp better
expect product save
ep
organ revenu growth
organ revenu growth organ
sale growth beyond
driven solid snack growth
impact om expand
bp annual post reinvest
price-to-earnings slightli lt histori reect
organ sale growth higher
organ sale growth higher
impact competit pressur
north america beverag higher covid-
impact on-premis channel along
competit environ drive
top-line growth valuat bear case
ep low end peer
upsid cost save
volum upsid
bp price pressur
top-line downsid
downsid fx/commod
strong top-line growth frito-lay north
higher reinvest pepsi-cola beverag
north america pbna drive improv
china india
view explan region hierarchi
research highest favor quintil
re-acceler flna snack top-line
busi higher invest spend better gm
expans favor commodities/bett
price realiz higher cost save
lower return reinvest macro
volatil commod fx volatil greater
covid impact greater competit beverag
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
pt deriv price-to-earnings ccep histor price-to-earnings reect high near-
sale western europ
channel exposur on-premis
channel see ccep high risk near-
term given gov mandat shut down
ccep lt top-line outlook lower vs cpg
peer given high csd-skew
volum exposur slower growth
europ howev forecast improv
energi drink ration price
environ model annual bp
margin expans post driven
price/mix realiz moder
bp expans synergi
realiz german/spanish
flat organ sale lower expect
impact coupl strong
price/mix realiz lead ccep
add valu appli
top-line declin
top-line declin forecast
organ sale declin
impact particularli on-premis
channel sale appli
price-to-earnings ccep histor price-to-earnings
top-line higher impact
top-line higher impact
weaker macro higher
headwind ccep on-premis sale drive
bp price upsid
bp volum upsid due share gains/macro
bp price downsid
bp volum downsid macros/sugar tax
synergi downsid
higher contribut innov
monster
save provid increment benet
view explan region hierarchi
accret acquisit new territori margin
upsid lower expect commod cost
higher contribut innov
higher volum growth non-csd
brand faster recoveri covid
volum pressur health/wel sugar
weak western europ macro condit
certain hedg fund exposur held mspb
inform may inconsist may reect
exposur short exposur sector total net
short exposur across sector long exposur
pt deriv ev/ebitda support base case dcf
analysi assum sales/nopat compound-annual-growth-rate wacc termin growth
growth low end lt target
driven legaci dp
kgm coffe busi good
visibl legaci dp organ top-line
better volum trend avor csd
legaci kgm single-serv busi
opaqu see potenti
cocoon home favor potenti
lt coffeesal see potenti risk
synergi target
synergi ow-through bottom
line rare achiev histor
cpg transact note howev
manag strong track record
impact coffe upsid lead
valuat ebitda
growth modest covid-
impact on-premis ga
synergi reach
top-line growth higher
top-line growth higher
impact higher expect neg
impact drive top-line growth
realiz synergi
valuat contract ebitda
us scanner data trend improv coffe pod
household penetr higher expect
view explan region hierarchi
research highest favor quintil
upsid dp cost synergi target higher volum
growth coffe higher household penetr
growth better coffe pod price keurig lt
contract top-line contribut alli brand
downsid dp synergi target slowdown
household penetr coffe busi
dp top-line slow wors market share
cycl price increas commod cost
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
weak fundament valuat keep us ew
pt deriv ev/ebitda multipl low-end peer
reect challeng top-line outlook higher debt leverag
growth challeng burden
exposur us beer categori
sale exacerb outsiz leverag
declin premium economi
segment us volum mix
compound-annual-growth-rate bottom hpc/bev
near term volum challeng us
commod cost high debt leverag
like weigh sentiment believ
take time revit
deliv improv fundament
result potenti hiccup given
scale restructur program
clear catalyst horizon
fundament pressur reect valuat
remain ew
top-line declin lower expect
upsid vs base base valuat expand
bull case ebitda
top-line declin organ sale
rang continu
declin us/canada
impact on-premis busi ebitda
declin rebas
new ceo attish post
appli ev/ebitda multipl
low-end peer reect challeng
top-line outlook higher debt leverag
us top-line deterior
us top-line deterior
impact on-premis busi
impact on-premis busi
organ top-line growth wors
expect impact
on-premis busi sale
valuat contract bear
usd weaken
bp margin downsid reinvest
usd strengthen
save realiz revit
china india
view explan region hierarchi
research highest favor quintil
price realiz higher contribut
inat commod fx volatil
impact macro risk
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
acceler top-line growth margin expans peer
pt base ep price-to-earnings multipl
discount averag target multipl multi-national cpg peer histor
bp volum upsid
save drive prot upsid
valuat ep impli
organ top-line growth ebit
organ top-line growth ebit
growth
growth sale growth
beyond om
bp annual top-line growth price
cost save support slightli
covid-rel pantri lling valuat
expand ep impli
top pick food
top pick food believ
organ sale growth
acceler sustain level
driven favor geographic/categori
exposur emerg market snack
categori strateg chang focu
local brand top-line expans chang
incent comp volum trend
rebound emerg market market
share trend improv higher
improv us top-line growth trend
growth prole similar mega-cap
cpg peer ko/pep/pg/cl andvalu
price-to-earnings look compel
discount mega-cap cpg peer
view descript risk reward theme
trend due lower inat emerg
market categori volum growth
fulli recov lower price
pressur health wellness/covid
concern usd appreci
valuat ep impli
bp top-line upsid mrkt share gain
higher categori expans especi
relat impact suppli chain
disrupt pantry-load
china india
view explan region hierarchi
research highest favor quintil
higher volum growth better expect
price covid pantry-load acceler
trend em improv snack categori
lower volum growth price weaker
price volum pressur categori
margin expans higher reinvest
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
pt deriv dcf valuat revenue/ebitda compound-annual-growth-rate post
wacc tgr exit multipl impli base ebitda
packag food peer rang given bearish lt top-line outlook
bp top-line upsid us market share
gain int upsid drive
organ sale compound-annual-growth-rate bps/yr
margin expans top-line leverag
resumpt product save drive
wacc tgr exit multipl
strateg premium consolid halo
stabil follow
expect ebitda declin
model stabil start
yr ebitda compound-annual-growth-rate growth outsid north
america mostli off-set continu
weak us/canada dcf input
wacc tgr exit
expect easi comp covid
relat pantry-l tailwind support
organ sale analysi
us busi sale
highlight leverag low/no growth
end market weak competit
posit forecast organ
expans drive prot margin
unsustain level see margin
core sg wide gap peer
trade ev/ebitda low
k/gis/sjm/cag reect limit
growth outlook higher risk
view descript risk reward theme
bp top-line downsid
declin bps/yr price pressur xed
cost de-lever higher reinvest
drive ebitda compound-annual-growth-rate dcf
post wacc tgr
yoy chg ebitda
yoy chg adj ep
us top-line growth trend price gap privat
label categori growth
cut asset sale
relat impact pantry-load
china india
view explan region hierarchi
research highest favor quintil
favor us food industri volum trend
potenti upcom strateg review
horizon
us food volum trend health/wel
continu spend cut widen price gap
privat label commod pressur potenti
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
valuat fair given organ top-line improv off-set weak prot outlook
pt deriv ev/ebitda roughli line current level
support dcf analysi topline/ebit growth wacc exit
expans re-rat
expans bp
volum upsid better market share
trend covid-rel pantri lling
pantry/shelf space price upsid
bp cost save upsid
multipl expand ebitda
organ sale growth
support temporari
covid-rel boost sale
longer term remain line
oper margin contract bp
reinvestment/brand-build expand
ev/ebitda impli
remain rang go forward
covid relat tailwind earli
pantri lling higher reinvest
contribut int growth longer term
lt org sale forecast
middl guidanc
includ futur believ
need continu reinvest
behind busi histor cutback
meet top-line growth goal
slight bp lt margin expans per
year valuat price-to-earnings
pension adjust basi report
price margin headwind
view descript risk reward theme
lower price weaker categori volum
lower price weaker categori volum
deterior bp privat label
slow health well pressur
commod inat higher valuat
contract ev/ebitda impli
bp price upsid
bp top-line upsid market share growth
share trend post pack
higher margin expans cost save
relat impact pantry-load
china india
view explan region hierarchi
research highest favor quintil
higher us snack growth
busi innov higher ad spend
higher margin expans greater cost save
moder commod
price pressur us sale
disrupt lower oper prot
growth higher reinvest need cost
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
fair valuat solid near-term top-line growth uncertain lt growth
pt deriv price-to-earnings base case ep standard
deviat last averag strong organ growth
worri long-term skew
lower growth competit us market
share gain temporari covid boost
drive solid corpor growth
valuat reason chd valuat
ep
somewhat elev vs cpg peer
view descript risk reward theme
laundri vitamin categori result
extend benet pantry-load drive
bp top-line upsid cost efcienc
weaker expect commod
inat drive increment basi
point gross margin upsid bp
price upsid appli multipl
standard deviat last
year averag bull case ep
org sale growth
long-term target benet
price-to-earnings base case ep
standard deviat last
year averag strong organ growth
growth bp forecast due
competit price pressur us
volum downsid consum de-load
reinvest compress valuat
deviat last
year averag bear case ep
strong pipelin innov key categori
top-lin growth facingcycl price
china india
view explan region hierarchi
research highest favor quintil
bp gm upsid weaker commod
bp us price upsid
bp us reinvest
bp us volum downsid
bp us price pressur
organ sale growth sustain rang
lower commod product higher
expect potenti accret acquisit
consolid
competit price us promot
intens key categori ramp us volum
commod inat execut risk
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
pt deriv froma price-to-earnings multipl given recent acceler growth
improv fundament org sale growth given temporari benet
long-term greater reinvest stronger innov
organ top-line drive multipl
organ top-line drive multipl
expans bp volum upsid
share gain increment sale relat
concern bp price
upsid drive multipl expans
top-line growth rang
top-line growth rang
org sale growth given temporari
benet long-term
greater reinvest stronger
cl top pick hpc
cl top pick hpc follow
rebound top-line trend
expect organ sale growth reach
partli aid relat
pantri load importantli
improv market share trend
reinvest execut xe robust
innov believ cl exposur
higher-growth emerg market
revenu mix drive higher lt growth
although near-term fx pressur macro
volatil limit result colgat
ntm price-to-earnings discount large-cap household
product peer compel consid
recent acceler top-line trend cl
trade standard deviat
histor rel ntm price-to-earnings
long-term sale growth deceler
long-term sale growth deceler
drive bp price downsid bp
margin reinvest spur top-line
well bp volum downsid
weak/volatil macro difcult
competit environ drive bp
volum bp price invest
bp volum upsid share gain
 downsid bp volum bp price
 sale bp chang
realiz price emerg market
continu increas spend
china india
view explan region hierarchi
research highest favor quintil
ad spend int categori rebound macro
covid relat pantry-load consolid
weaker price market share loss
local player categori growth slowdown
stronger usd higher commod cost
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
pt deriv ep slightli averag
top-line margin upsid bp
better expect volum near-term
last bp margin upsid
declin commod cost
upsid cost-cut drive multipl
expans bull case ep
lower long-term ep growth peer
lower long-term ep growth peer
top line growth bp averag
margin expans near-term top-lin
acceler driven above-trendcovid-
relat demand growth clean
segment expect valuat
ep averag
rel hpc peer
rel hpc peer near-
term top-line like robustli
support covid-rel demand boost
clean product project
organ growth vs
driven busi relat
clean believ longer term
remain overindex low-growth
product categori high exposur
us
ev/ebitda
price-to-earnings high comparison pg
growth strateg potenti rel
view descript risk reward theme
hpc environ drive bp us price
downsid coupl bp volum
downsid near-term covid-rel
demand dissip post
margin reinvest busi
multipl compress bear case
gross margin chang bp
advertis cost sale chang
bp
oper margin chang bp
impact boost sale wipe
improv price gap privat label key
shelf space recaptur innov
china india
view explan region hierarchi
research highest favor quintil
million increment save
bp reinvest
top-line margin upsid improv price
better expect volum declin
cost-cut
price take hold worsen volum
higher expect commod inat
heighten competit privat label
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
lt growth potenti temper impact
pt deriv price-to-earnings multipl ebitda el three-
yr average higher risk premium household product peer given stronger lt growth
potenti post near-term covid impact favor prestig beauti categori exposur
term covid
term covid see stronger lt el
growth peer el share gain
high growth high-end beauti categori
near-term downsid covid-rel
pressur retail store closur
trade-down risk macro pressur
price-to-earnings in-lin ve-year
averag look fair potenti
return outsizedlt growth post
earli resolut disrupt
earli resolut disrupt
neg impact viru
declin travel retail
declin china
disrupt larg restrict
recoveri top-line
forecast increment pressur
recov el also deliv
cost-cut upsid valuat expand
ep buoy strateg halo
growth declin china declin
travel retail drive organ
sale declin rebound
cost-cut support margin
impact prolong coronaviru
disrupt top-line growth
base case continu brick
mortar store closur andconsum
contract ep
top-line upsid
earli resolut coronaviru impact
top-line downsid
reinvest
este lauder compani inc sanford bernstein strateg
viru impact travel retail/china
china india
view explan region hierarchi
research highest favor quintil
lower expect covid impact
growth rebound prestig beauti market share
gain key categori favor fx movement
tariff/boycott risk categori growth
share loss competit price unfavor
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
pt deriv froma ebitda in-lin secularli challeng name
remain low categori growth
remain soft near-term impact
retail landscap remain
challeng cost busi
appear high exacerb challeng
present coronaviru outbreak
valuat warrant given lack
valuat warrant given lack
visibl trade low end
peer pro-forma ev/ebitda
look fair consid visibl around
potenti larg cost save
opportun off-set reinvest risk
revenu upsid greater synergi
revenu upsid greater synergi
share gain drive top-line upsid
realiz net synergi upsid vs
forecast drive multipl expans
modest top-line growth augment
modest top-line growth augment
sale declin follow sever
impact coronaviru disrupt
cost save drive om expans
appli ebitda in-
line secularli challeng name
revenu downsid tariff risk
revenu downsid tariff risk weaken
categori growth prolong
downsid tariff risk lower net
downsid vs base case multipl
compress ebitda
china india
view explan region hierarchi
research highest favor quintil
synergi realiz higher expect market
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
valuat look fair reect mute top-line growth visibl
pt deriv base ebitda discount peer given
expect organ top-line sever impact coronaviru pressur declin
expect gradual improv slight
organ sale growth well peer
sever near-term impact
earn visibl high leverag
earn visibl high leverag
trade valuat discount
attract beauti peer believ
earn visibl high net
consum beauti declin augment
bp upsid luxuri earli
resolut coronaviru outbreak
sharp top-line declin organ top-line
sever impact coronaviru pressur
declin
pressur consum beauti off-set
steadi lsd growth luxuri
organ sale declin continu
continu margin pressur particularli
luxuri profession busi
remain close experi reduc foot
synergi upsid
bp volum downsid
synergi downsid
synergy/cost save realiz kyli deal
impact beauti category/suppli
china india
view explan region hierarchi
research highest favor quintil
higher expect synergy/cost save
realiz licens chang upsid
chain risk shelf space loss consum beauti
fund exposur held mspb inform may
inconsist may reect broader market
exposur sector total net exposur
across sector long exposur short exposur
